ONO Announces Winner of 2023 Golden Ticket Competition

ONO and MBC BioLabs are delighted to announce Tippingpoint Biosciences as the winner of their “2023 Golden Ticket Competition”. The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation for the potential future benefit of patients worldwide.

About Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd., headquarterd in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on the oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company’s website at https://www.ono-pharma.com/.